Pharmacogenetics in rheumatology: drug therapy individualization perspectives

Pharmacogenetics in rheumatology: drug therapy individualization perspectives

Saved in:

Bibliographic Details
Main Authors:	D. A. Sychev, F V Ignatiev, R E Kasakov, G V Ramenskaya, G N Alexeeva, M. V. Zuravleva, V G Kukes
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2005-10-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/329
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacogenetics of HMG-CoA reductase inhibitors (statins): perspectives of individualized, genotype-based therapy
by: D. A. Sychev, et al.
Published: (2006-02-01)

Clinical pharmacogenetics of angiotensin II receptor blockers: new perspectives of pharmacotherapy individualization
by: D. A. Sychev, et al.
Published: (2006-04-01)

Glycoprotein P pharmacogenetic assessment role in digoxin pharmacotherapy individualization: a new approach for an old problem
by: D. A. Sychev, et al.
Published: (2006-08-01)

Significance of pharmacogenetic testing in solution of problem of nonsteroid antirheumatic drugs administration gastro-intestinal safety
by: A Y Obzerina, et al.
Published: (2009-06-01)

VARFARIN DOSE REGIME APPROACHS BASED ON PHARMACOGENETICS TEST RESULTS: REAL POSSIBILITY TO OPTIMIZE THE PHARMACOTHERAPY
by: D. A. Sychev, et al.
Published: (2015-12-01)

ANTI-TNF THERAPY PERSPECTIVES IN RHEUMATOLOGIC PRACTICE
by: E.I. Alexeeva, et al.
Published: (2008-01-01)

Pharmacogenetics and individualized approach to the therapy of bronchial asthma
by: Ivan I. Balabolkin, et al.
Published: (2017-07-01)

Clinical pharmacogenetics of antiaggregants: clinical pharmacologist' point of view
by: D. A. Syche, et al.
Published: (2007-08-01)

The pharmacogenetics antiepileptic drugs
by: N. A. Shnayder, et al.
Published: (2008-12-01)

THE SPECIFIC FEATURES OF THE PHASE I OF CLINICAL INVESTIGATIONS OF DRUGS
by: A. Y. Savchenko, et al.
Published: (2012-09-01)

APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA
by: D. A. Sychev, et al.
Published: (2015-09-01)

ARE ALL THE PROLONGED DRUG FORMULATIONS OF NIFEDIPINE THE SAME?
by: V. G. Kukes, et al.
Published: (2016-01-01)

PHARMACOGENETIC BASES OF INDIVIDUAL SENSITIVITY AND PERSONALIZED ADMINISTRATION OF ANTIPLATELET THERAPY IN DIFFERENT ETHNIC GROUPS
by: B. I. Kantemirova, et al.
Published: (2021-05-01)

Rheumatology of Orenburg region: achievements and perspectives
by: V V Bagirova, et al.
Published: (2003-06-01)

Organo-protective effects of quinapril: pharmacogenetic aspects
by: D. A. Sychev, et al.
Published: (2011-04-01)

PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION
by: A. V. Kryukov, et al.
Published: (2017-07-01)

Pharmacogenetics of carbamazepine
by: N. A. Shnayder, et al.
Published: (2020-01-01)

Evaluation of the multiple doses thiozonide’s pharmacokinetics in patients diagnosed with pulmonary tuberculosis with multidrug-resistant or extensively drug-resistant <i>Mycobacterium tuberculosis</i>
by: А. Yu. Savchenko, et al.
Published: (2024-01-01)

EFFECT OF GENES SLCO1B1 AND MDR1 POLYMORPHISM ON ATORVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: RESULTS OF PILOT PHARMACOGENETICS STUDY
by: A. V. Semenov, et al.
Published: (2016-01-01)

Pharmacogenetics of Antiplatelet Drugs
by: Ronan Curtin, et al.
Published: (2002-01-01)

Pharmacogenetics of antiretroviral drugs
by: Dragović Gordana, et al.
Published: (2012-01-01)

OPPORTUNITIES TO OPTIMIZE ANTIEPILEPTIC THERAPY WITH USE OF PHARMACOGENETIC BIOMARKERS
by: T. V. Dokukina, et al.
Published: (2016-05-01)

Mechanisms of development of antipsychotic-induced metabolic disorders: pharmacogenetic aspect
by: R. F. Nasyrova, et al.
Published: (2018-01-01)

Pharmacokinetics and Pharmacogenetics of Dabigatran
by: A. V. Savinova, et al.
Published: (2021-03-01)

APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY
by: D. A. Sychev, et al.
Published: (2015-09-01)

Pharmacogenetic aspects of the efficacy of nonsteroidal anti-inflammatory drugs and opioid analgesics for postoperative pain relief after total joint arthroplasty
by: A. S. Zhiryakova, et al.
Published: (2025-06-01)

Pharmacogenetic aspects of the effectiveness of nonsteroidal anti-inflammatory drugs and opioids for postoperative pain management in patients after total joint arthroplasty
by: A. S. Zhiryakova, et al.
Published: (2020-12-01)

PHARMACOGENETIC FEATURES OF THERAPY OF PATIENTS WITH ATHEROSCLEROSIS
by: A. L. Khokhlov, et al.
Published: (2018-02-01)

INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRIC RHEUMATOLOGY PRACTICE
by: E. I. Alexeeva, et al.
Published: (2015-04-01)

Patients’ Pharmacogenetic Characteristics and the Risk of Adverse Reactions to Non-steroidal Anti-inflammatory Drugs: Case Reports
by: A. S. Zhiryakova, et al.
Published: (2024-07-01)

Pharmacokinetics and Pharmacogenetics of Apixaban
by: A. V. Savinova, et al.
Published: (2020-11-01)

Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapy
by: Defa Huang, et al.
Published: (2024-12-01)

PHARMACOGENETIC STUDIES IN CARDIOLOGY: THE PROBLEM OF "DEPTH" OF THE ISSUE STUDY AND THE CORRECTNESS OF USING "GENETIC" TERMS
by: D. A. Sychev, et al.
Published: (2018-03-01)

RITUXIMAB IN PEDIATRIC RHEUMATOLOGY
by: E.I. Alexeeva, et al.
Published: (2010-05-01)

Pharmacogenetic Aspects of Postoperative Anesthesia with Ketoprofen in Cardiac Surgery Patients
by: T. E. Morozova, et al.
Published: (2021-11-01)

Place of topical therapy in rheumatology. Ketoprofen gel is a focus
by: V G Barskova, et al.
Published: (2008-09-01)

Pharmacogenetic Markers of Favipiravir Safety in COVID-19 Treatment
by: I. I. Temirbulatov, et al.
Published: (2023-10-01)

Pharmacogenetics biomarkers of antipsychotics’ safety in adolescents with acute psychotic episode
by: D. V. Ivashchenko, et al.
Published: (2019-12-01)

THE COMPARATIVE EFFICACY OF PERSONALIZING THERAPY WITH ANTICONVULSANTS AND ANTIPSYCHOTICS ON THE BASIS OF PHARMACOGENETIC TESTING
by: T. V. Dokukina, et al.
Published: (2016-08-01)

Pharmacogenetics of Community-Acquired Pneumonia
by: S. SH. Suleimanov, et al.
Published: (2020-05-01)